• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of opioid management >A claims analysis of the utilization of tramadol for acute pain in patients prescribed buprenorphine/naloxone for opioid use disorder.
【24h】

A claims analysis of the utilization of tramadol for acute pain in patients prescribed buprenorphine/naloxone for opioid use disorder.

机译：一种乳腺癌曲马多患者抗胰岛素患者急性疼痛的索引分析，用于阿片类药物使用障碍。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

To determine the prevalence of tramadol prescribing among commercially insured adults receiving medication-assisted therapy (MAT) with buprenorphine/naloxone. The authors conducted a cross-sectional descriptive study to evaluate the use of tramadol among patients prescribed buprenorphine/suboxone for MAT. This study utilized data from 2010 to 2013 Optum? Clinformatics? Data Mart. This cohort is an administrative health claims database from a large national insurer. These data included pharmacy and medical care utilization and information describing patient enrollment. Patients were 12-64 years of age and had complete and available medical, pharmacy, and administrative records in the Optum Clinformatics Data Mart during the study period. Patients who received at least one paid claim for buprenorphine/naloxone from 2010 to 2013 and also received at least one overlapping pharmacy dispensing for tramadol were identified for analysis. The authors determined if the concurrent buprenorphine/naloxone and tramadol dispensings were from the same or a different prescriber. In this analysis of 18,734 US commercially insured patients receiving MAT with buprenorphine/naloxone, the authors identified 1,198 (6.4 percent) patients who received at least one overlapping dispensing for tramadol during a 4-year period spanning 2010-2013. Among these patients, 266 (1.42 percent) were co-prescribed buprenorphine/naloxone and tramadol from the same provider. These results suggest that the use of tramadol among patients receiving buprenorphine/naloxone is not uncommon. Further study is warranted to further determine the benefits and risks associated with the use of tramadol for pain management among patients prescribed buprenorphine/naloxone.
机译：确定与丁丙诺啡/纳洛酮接受药物辅助治疗（MAT）的商业上保险成人中曲马多的患病率。作者进行了横截面描述性研究，以评估使用曲马多的曲马多甲丙啡/亚酮垫的使用。本研究利用2010年至2013年奥波姆的数据？ Clipformatics？数据库。该队列是一家大型国家保险公司的行政健康索赔数据库。这些数据包括药房和医疗利用和描述患者入学的信息。患者12-64岁，在研究期间，奥普拉姆担保人数据集市中有完整和医疗，药房和行政记录。从2010年至2013年接受至少一项已支付的Buprenorphine / Naloxone索赔的患者并鉴定了至少一种对曲马多的重叠药房分配进行分析。作者确定了同时丁丙诺啡/纳洛酮和曲马多的分配来自相同或不同的处方。在该分析中，18,734件美国商业投保患者接受丁丙诺啡/纳洛酮，作者鉴定了1,198名（6.4％）患者，该患者在2010-2013的4年期间接受了曲马多的重叠分配。在这些患者中，266名（1.42％）是来自同一供应商的共同规定的丁丙诺啡/纳洛酮和曲马多。这些结果表明，接受Buprenorphine / Naloxone患者的曲马多的使用并不罕见。有必要进一步研究，以进一步确定与使用曲马多的患者患者患者患者患者患者患者患者进行耐受曲折的益处和风险。

著录项

  • 来源
    《Journal of opioid management》 |2018年第6期|共7页
  • 作者

    Kellye Donovan; Stephen Kogut; Ashley Buchanan; Xuerong Wen; Robert Crausman;

  • 作者单位

    Program in Health Outcomes Department of Pharmacy Practice College of Pharmacy University of;

    Program in Health Outcomes Department of Pharmacy Practice College of Pharmacy University of;

    Program in Health Outcomes Department of Pharmacy Practice College of Pharmacy University of;

    Program in Health Outcomes Department of Pharmacy Practice College of Pharmacy University of;

    President Trumed Medical Offices Fall River Massachusetts;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号